Top compounds associated with response to IRAK1BP1


Feature Type Standardized
Nominal ANOVA
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA KPT185 CTRPv2 pan-cancer AAC 0.23 6e-09
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-08
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.17 2e-08
mRNA indisulam CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA ouabain CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.18 4e-08
Download CSV